 | • レポートコード：MRC2012A3032 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ドライアイ治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。ドライアイ治療薬の種類別市場規模（人工涙液、抗炎症薬、その他）、用途別市場規模（病院、ドラッグストア、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Allergan、Senju Pharmaceutical、Santen Pharma、Novartis AG、United Laboratories、Bausch Health、Eusan GMBH、Johnson & Johnson、Takeda、Jianfeng Group、 ・地域別グローバル市場分析 2015年-2020年 ・ドライアイ治療薬の北米市場（アメリカ、カナダ、メキシコ） ・ドライアイ治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ドライアイ治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ドライアイ治療薬の南米市場（ブラジル、アルゼンチン） ・ドライアイ治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：人工涙液、抗炎症薬、その他 ・用途別分析：病院、ドラッグストア、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Dry Eye Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Dry Eye Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.5%% in the forecast period of 2020 to 2025 and will expected to reach USD 10780 million by 2025, from USD 6979.2 million in 2019.
Market segmentation
Dry Eye Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Dry Eye Drugs market has been segmented into
Artificial Tears
Anti-inflammatory Drugs
Other
By Application, Dry Eye Drugs has been segmented into:
Hospital
Drug Stores
Online Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Dry Eye Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Dry Eye Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Dry Eye Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Dry Eye Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Dry Eye Drugs Market Share Analysis
Dry Eye Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Dry Eye Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Dry Eye Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Dry Eye Drugs are:
Allergan
Senju Pharmaceutical
Santen Pharma
Novartis AG
United Laboratories
Bausch Health
Eusan GMBH
Johnson & Johnson
Takeda
Jianfeng Group
Among other players domestic and global, Dry Eye Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dry Eye Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dry Eye Drugs, with price, sales, revenue and global market share of Dry Eye Drugs in 2018 and 2019.
Chapter 3, the Dry Eye Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dry Eye Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Dry Eye Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Dry Eye Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Dry Eye Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dry Eye Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Artificial Tears
1.2.3 Anti-inflammatory Drugs
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Dry Eye Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.4 Overview of Global Dry Eye Drugs Market
1.4.1 Global Dry Eye Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan SWOT Analysis
2.1.4 Allergan Product and Services
2.1.5 Allergan Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Senju Pharmaceutical
2.2.1 Senju Pharmaceutical Details
2.2.2 Senju Pharmaceutical Major Business
2.2.3 Senju Pharmaceutical SWOT Analysis
2.2.4 Senju Pharmaceutical Product and Services
2.2.5 Senju Pharmaceutical Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Santen Pharma
2.3.1 Santen Pharma Details
2.3.2 Santen Pharma Major Business
2.3.3 Santen Pharma SWOT Analysis
2.3.4 Santen Pharma Product and Services
2.3.5 Santen Pharma Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business
2.4.3 Novartis AG SWOT Analysis
2.4.4 Novartis AG Product and Services
2.4.5 Novartis AG Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 United Laboratories
2.5.1 United Laboratories Details
2.5.2 United Laboratories Major Business
2.5.3 United Laboratories SWOT Analysis
2.5.4 United Laboratories Product and Services
2.5.5 United Laboratories Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bausch Health
2.6.1 Bausch Health Details
2.6.2 Bausch Health Major Business
2.6.3 Bausch Health Product and Services
2.6.4 Bausch Health Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Eusan GMBH
2.7.1 Eusan GMBH Details
2.7.2 Eusan GMBH Major Business
2.7.3 Eusan GMBH Product and Services
2.7.4 Eusan GMBH Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Product and Services
2.8.4 Johnson & Johnson Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Takeda
2.9.1 Takeda Details
2.9.2 Takeda Major Business
2.9.3 Takeda Product and Services
2.9.4 Takeda Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Jianfeng Group
2.10.1 Jianfeng Group Details
2.10.2 Jianfeng Group Major Business
2.10.3 Jianfeng Group Product and Services
2.10.4 Jianfeng Group Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Dry Eye Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Dry Eye Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Dry Eye Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Dry Eye Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Dry Eye Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Dry Eye Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Dry Eye Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Dry Eye Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Dry Eye Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Dry Eye Drugs Sales and Growth Rate (2015-2020)
4.5 South America Dry Eye Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Dry Eye Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Dry Eye Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Dry Eye Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Dry Eye Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Dry Eye Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Dry Eye Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Dry Eye Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Dry Eye Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Dry Eye Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Dry Eye Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Dry Eye Drugs Sales and Growth Rate (2015-2020)
6.3 UK Dry Eye Drugs Sales and Growth Rate (2015-2020)
6.4 France Dry Eye Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Dry Eye Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Dry Eye Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Dry Eye Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Dry Eye Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Dry Eye Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Dry Eye Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Dry Eye Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Dry Eye Drugs Sales and Growth Rate (2015-2020)
7.5 India Dry Eye Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Dry Eye Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Dry Eye Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Dry Eye Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Dry Eye Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Dry Eye Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Dry Eye Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Dry Eye Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Dry Eye Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Dry Eye Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Dry Eye Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Dry Eye Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Dry Eye Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Dry Eye Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Dry Eye Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Dry Eye Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Dry Eye Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Dry Eye Drugs Price by Type (2015-2020)
11 Global Dry Eye Drugs Market Segment by Application
11.1 Global Dry Eye Drugs Sales Market Share by Application (2015-2020)
11.2 Global Dry Eye Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Dry Eye Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Dry Eye Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Dry Eye Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Dry Eye Drugs Market Forecast (2021-2025)
12.2.2 Europe Dry Eye Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Dry Eye Drugs Market Forecast (2021-2025)
12.2.4 South America Dry Eye Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Dry Eye Drugs Market Forecast (2021-2025)
12.3 Dry Eye Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Dry Eye Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Dry Eye Drugs Market Share Forecast by Type (2021-2025)
12.4 Dry Eye Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Dry Eye Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Dry Eye Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Dry Eye Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Dry Eye Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Dry Eye Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Dry Eye Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Allergan Basic Information, Manufacturing Base and Competitors
Table 9. Allergan Dry Eye Drugs Major Business
Table 10. Allergan Dry Eye Drugs Total Revenue (USD Million) (2018-2019)
Table 11. Allergan SWOT Analysis
Table 12. Allergan Dry Eye Drugs Product and Services
Table 13. Allergan Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Senju Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 15. Senju Pharmaceutical Dry Eye Drugs Major Business
Table 16. Senju Pharmaceutical Dry Eye Drugs Total Revenue (USD Million) (2018-2019)
Table 17. Senju Pharmaceutical SWOT Analysis
Table 18. Senju Pharmaceutical Dry Eye Drugs Product and Services
Table 19. Senju Pharmaceutical Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Santen Pharma Basic Information, Manufacturing Base and Competitors
Table 21. Santen Pharma Dry Eye Drugs Major Business
Table 22. Santen Pharma Dry Eye Drugs Total Revenue (USD Million) (2018-2019)
Table 23. Santen Pharma SWOT Analysis
Table 24. Santen Pharma Dry Eye Drugs Product and Services
Table 25. Santen Pharma Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 27. Novartis AG Dry Eye Drugs Major Business
Table 28. Novartis AG Dry Eye Drugs Total Revenue (USD Million) (2018-2019)
Table 29. Novartis AG SWOT Analysis
Table 30. Novartis AG Dry Eye Drugs Product and Services
Table 31. Novartis AG Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. United Laboratories Basic Information, Manufacturing Base and Competitors
Table 33. United Laboratories Dry Eye Drugs Major Business
Table 34. United Laboratories Dry Eye Drugs Total Revenue (USD Million) (2018-2019)
Table 35. United Laboratories SWOT Analysis
Table 36. United Laboratories Dry Eye Drugs Product and Services
Table 37. United Laboratories Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 39. Bausch Health Dry Eye Drugs Major Business
Table 40. Bausch Health Dry Eye Drugs Total Revenue (USD Million) (2018-2019)
Table 41. Bausch Health SWOT Analysis
Table 42. Bausch Health Dry Eye Drugs Product and Services
Table 43. Bausch Health Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Eusan GMBH Basic Information, Manufacturing Base and Competitors
Table 45. Eusan GMBH Dry Eye Drugs Major Business
Table 46. Eusan GMBH Dry Eye Drugs Total Revenue (USD Million) (2018-2019)
Table 47. Eusan GMBH SWOT Analysis
Table 48. Eusan GMBH Dry Eye Drugs Product and Services
Table 49. Eusan GMBH Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 51. Johnson & Johnson Dry Eye Drugs Major Business
Table 52. Johnson & Johnson Dry Eye Drugs Total Revenue (USD Million) (2018-2019)
Table 53. Johnson & Johnson SWOT Analysis
Table 54. Johnson & Johnson Dry Eye Drugs Product and Services
Table 55. Johnson & Johnson Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Takeda Basic Information, Manufacturing Base and Competitors
Table 57. Takeda Dry Eye Drugs Major Business
Table 58. Takeda Dry Eye Drugs Total Revenue (USD Million) (2018-2019)
Table 59. Takeda SWOT Analysis
Table 60. Takeda Dry Eye Drugs Product and Services
Table 61. Takeda Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Jianfeng Group Basic Information, Manufacturing Base and Competitors
Table 63. Jianfeng Group Dry Eye Drugs Major Business
Table 64. Jianfeng Group Dry Eye Drugs Total Revenue (USD Million) (2018-2019)
Table 65. Jianfeng Group SWOT Analysis
Table 66. Jianfeng Group Dry Eye Drugs Product and Services
Table 67. Jianfeng Group Dry Eye Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Global Dry Eye Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 69. Global Dry Eye Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 70. Global Dry Eye Drugs Sales by Regions (2015-2020) (K Units)
Table 71. Global Dry Eye Drugs Sales Market Share by Regions (2015-2020)
Table 72. Global Dry Eye Drugs Revenue by Regions (2015-2020) (USD Million)
Table 73. North America Dry Eye Drugs Sales by Countries (2015-2020) (K Units)
Table 74. North America Dry Eye Drugs Sales Market Share by Countries (2015-2020)
Table 75. North America Dry Eye Drugs Revenue by Countries (2015-2020) (USD Million)
Table 76. North America Dry Eye Drugs Revenue Market Share by Countries (2015-2020)
Table 77. Europe Dry Eye Drugs Sales by Countries (2015-2020) (K Units)
Table 78. Europe Dry Eye Drugs Sales Market Share by Countries (2015-2020)
Table 79. Europe Dry Eye Drugs Revenue by Countries (2015-2020) (USD Million)
Table 80. Asia-Pacific Dry Eye Drugs Sales by Regions (2015-2020) (K Units)
Table 81. Asia-Pacific Dry Eye Drugs Sales Market Share by Regions (2015-2020)
Table 82. Asia-Pacific Dry Eye Drugs Revenue by Regions (2015-2020) (USD Million)
Table 83. South America Dry Eye Drugs Sales by Countries (2015-2020) (K Units)
Table 84. South America Dry Eye Drugs Sales Market Share by Countries (2015-2020)
Table 85. South America Dry Eye Drugs Revenue by Countries (2015-2020) (USD Million)
Table 86. South America Dry Eye Drugs Revenue Market Share by Countries (2015-2020)
Table 87. Middle East & Africa Dry Eye Drugs Sales by Countries (2015-2020) (K Units)
Table 88. Middle East & Africa Dry Eye Drugs Sales Market Share by Countries (2015-2020)
Table 89. Middle East & Africa Dry Eye Drugs Revenue by Countries (2015-2020) (USD Million)
Table 90. Middle East & Africa Dry Eye Drugs Revenue Market Share by Countries (2015-2020)
Table 91. Global Dry Eye Drugs Sales by Type (2015-2020) (K Units)
Table 92. Global Dry Eye Drugs Sales Share by Type (2015-2020)
Table 93. Global Dry Eye Drugs Revenue by Type (2015-2020) (USD Million)
Table 94. Global Dry Eye Drugs Revenue Share by Type (2015-2020)
Table 95. Global Dry Eye Drugs Sales by Application (2015-2020) (K Units)
Table 96. Global Dry Eye Drugs Sales Share by Application (2015-2020)
Table 97. Global Dry Eye Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 98. Global Dry Eye Drugs Market Share Forecast by Regions (2021-2025)
Table 99. Global Dry Eye Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 100. Global Dry Eye Drugs Market Share Forecast by Type (2021-2025)
Table 101. Global Dry Eye Drugs Sales Forecast by Application (2021-2025)
Table 102. Global Dry Eye Drugs Market Share Forecast by Application (2021-2025)
Table 103. Direct Channel Pros & Cons
Table 104. Indirect Channel Pros & Cons
Table 105. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Dry Eye Drugs Picture
Figure 2. Global Sales Market Share of Dry Eye Drugs by Type in 2019
Figure 3. Artificial Tears Picture
Figure 4. Anti-inflammatory Drugs Picture
Figure 5. Other Picture
Figure 6. Dry Eye Drugs Sales Market Share by Application in 2019
Figure 7. Hospital Picture
Figure 8. Drug Stores Picture
Figure 9. Online Pharmacies Picture
Figure 10. Global Dry Eye Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Dry Eye Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Dry Eye Drugs Sales Market Share by Manufacturer in 2019
Figure 31. Global Dry Eye Drugs Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Dry Eye Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Dry Eye Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Dry Eye Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Dry Eye Drugs Revenue Market Share by Regions (2015-2020)
Figure 38. Global Dry Eye Drugs Revenue Market Share by Regions in 2018
Figure 39. North America Dry Eye Drugs Sales and Growth Rate (2015-2020)
Figure 40. Europe Dry Eye Drugs Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Dry Eye Drugs Sales and Growth Rate (2015-2020)
Figure 42. South America Dry Eye Drugs Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Dry Eye Drugs Sales and Growth Rate (2015-2020)
Figure 44. North America Dry Eye Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Dry Eye Drugs Sales Market Share by Countries (2015-2020)
Figure 46. North America Dry Eye Drugs Sales Market Share by Countries in 2018
Figure 47. North America Dry Eye Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Dry Eye Drugs Revenue Market Share by Countries in 2018
Figure 49. United States Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Dry Eye Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Dry Eye Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Dry Eye Drugs Revenue Market Share by Countries in 2019
Figure 55. Germany Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Dry Eye Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Dry Eye Drugs Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Dry Eye Drugs Revenue Market Share by Regions 2019
Figure 63. China Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Dry Eye Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Dry Eye Drugs Sales Market Share by Countries in 2019
Figure 70. South America Dry Eye Drugs Revenue Market Share by Countries in 2019
Figure 71. Brazil Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Dry Eye Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Dry Eye Drugs Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Dry Eye Drugs Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Dry Eye Drugs Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Dry Eye Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Dry Eye Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Dry Eye Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Dry Eye Drugs Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Dry Eye Drugs Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Dry Eye Drugs Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Dry Eye Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Dry Eye Drugs Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…- 眼科用治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ophthalmic Therapeutic Drugs Market The global Ophthalmic Therapeutic Drugs market size is projected to reach US$ 16740 million by 2026, from US$ 15860 million in 2020, at a CAGR of 5.2%% during 2021-2026. Global Ophthalmic Therapeutic Drugs Scope and Market Size…
- バーター症候群治療薬の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% d…
- 抗炎症薬の世界市場（～2026年） Market Analysis and Insights: Global Anti-inflammatory Drugs Market The global Anti-inflammatory Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti-inflammatory Drugs Scope and Market Size Anti-inflammatory Dru…
- ドライアイ治療薬・装置治療の世界市場（～2026年） Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry e…